Premier Cryogenics LimitedUnlisted Shares
₹ 323▲0.00%(0.00)
About the company
Premier Cryogenics Limited is one of the leading manufacturers and suppliers of industrial and medical gases in India's North-East region. Established in 1996, the company has built a strong reputation for delivering high-quality gas products and reliable solutions to industries including healthcare, manufacturing, engineering, infrastructure, pharmaceuticals, and research institutions. With decades of industry experience, Premier Cryogenics has become a trusted partner for businesses requiring consistent and efficient gas supply.
The company's extensive product portfolio includes Liquid Nitrogen, Liquid Oxygen, Industrial Oxygen, Medical Oxygen, Industrial and High-Purity Nitrogen Gas, Dissolved Acetylene, Dry Compressed Air, and a wide range of specialty gases such as Helium, Hydrogen, Freon, Calibration Gases, Gas Mixtures, and Ultra-High Purity Gases. In addition to gas manufacturing and distribution, the company supplies essential gas industry equipment and accessories, including cylinders, cryogenic liquid containers, valves, pressure regulators, and other critical components, enabling customers to source complete gas handling solutions from a single provider.
Fundamentals
Valuation
- 52 week high
- —
- 52 week low
- —
- P/B ratio
- 1.83
- Debt to equity
- 0.27
- ROE (%)
- 14.03%
- Book value
- ₹176.71
- Face value
- ₹10
- Valuation
- —
Registry
- ISIN number
- INE101F01017
Figures in lk ·
Financials
| P&L Statement | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue | 5681 | 9524 | 7748 |
| EBITDA | 1520 | 2689 | 2282 |
| OPM | 26.76 | 28.23 | 29.45 |
| PBT | 964 | 2175 | 1616 |
| PAT | 718 | 1637 | 1219 |
| EPS | 14.34 | 32.7 | 24.35 |
Shareholding Pattern
Frequently asked questions
Common questions on Premier Cryogenics Limited Unlisted Shares—tap a row to read the answer.
Q.1What does Premier Cryogenics Limited do?
Premier Cryogenics Limited is an industrial and medical gases manufacturer established in 1996. The company produces products such as Liquid Oxygen, Liquid Nitrogen, Medical Oxygen, Industrial Oxygen, High-Purity Nitrogen, Dissolved Acetylene, and Dry Compressed Air. It also supplies specialty gases, cryogenic equipment, cylinders, valves, pressure regulators, and other components used across industries including healthcare, manufacturing, engineering, pharmaceuticals, and research laboratories.
Q.2Can I buy Premier Cryogenics Limited unlisted shares?
Yes. Investors can purchase Premier Cryogenics Limited unlisted shares through off-market transactions, subject to the availability of shares. Since the company is not listed on a recognized stock exchange, these transactions take place privately between buyers and sellers, with the shares being transferred electronically to the investor's demat account after the necessary documentation is completed.
Q.3Is investing in Premier Cryogenics Limited unlisted shares legal in India?
Yes. Buying and selling unlisted shares is legal in India when the transaction complies with applicable regulations and is completed through the prescribed depository process. Investors should ensure that the shares are transferred through a valid demat account and that all required documentation is properly verified before investing.
Q.4What should investors evaluate before investing in Premier Cryogenics Limited?
Before investing, investors should review the company's financial performance, revenue growth, profitability, manufacturing capacity, customer base, management quality, industry outlook, and future expansion plans. It is also important to understand the company's valuation, competitive position, and the liquidity risks associated with unlisted shares before making an investment decision.
Q.5Why are investors interested in Premier Cryogenics Limited?
Premier Cryogenics Limited operates in the industrial and medical gases sector, which plays a critical role in healthcare, manufacturing, infrastructure, pharmaceuticals, and scientific research. Increasing industrial activity, rising healthcare demand, and infrastructure development continue to support long-term demand for industrial gases, making companies in this sector attractive to long-term investors.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
